Policymakers around the world are developing guidelines for use of artificial intelligence in health care.
Scholars discuss the challenges of promoting antibiotic development and preserving existing drugs.
The booming U.S. egg donation industry requires more regulation to safeguard donor welfare.
The structure of some essential oils companies makes it harder for federal agencies to restrain false claims.
Scholars explore how Section 1115 waivers can expand or reduce health coverage.
Advocates argue that FDA’s lax tampon regulations leave consumers exposed to significant risks.
Amid rising insured rates, physician shortages, and COVID-19, nurse-led care seeks to address health inequities.
Scholar argues for increased monitoring and regulatory coordination to curb zoonotic disease spread.
HIPAA consistently falls behind health and wellness technology, jeopardizing individuals’ data privacy.
The HIPAA privacy rule exemplifies HIPAA’s strengths and weaknesses.
HIPAA does not go far enough to protect health-related information inferred from location data collected by cellphones.
Recent changes to patient right of access policies could open the door to increased privacy challenges.